Home-based upper limb rehabilitation with the Neofect Smart Board for late subacute and chronic brain disorder patients
Official title: A Multicenter Confirmation Clinical Trial of Untact Upper Extremity Rehabilitation Using Smart Board for Late Subacute and Chronic Patients With Brain Disorder - a Randomized Single-blinded Controlled Trial
Run by Samsung Medical Center · NCT06837363 · Data updated 2026-11-12
This trial will test whether home-based arm exercises using the Neofect Smart Board help adults (19–85) with lasting arm weakness from stroke, traumatic brain injury, or brain tumor more than conventional home occupational therapy.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 19 Years to 85 Years |
| Sex | All |
| Enrollment | 40 (estimated) |
| Sponsor | Samsung Medical Center Academic / other |
| Locations | 1 site (Seoul) |
| Status | Recruiting |
| Started | April 1, 2025 |
| Main results expected | December 31, 2026 |
| Study ends | December 31, 2026 |
| Registry record updated | April 24, 2026 |
| Trial ID | NCT06837363 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 19–85 with hemiparesis lasting more than three months from stroke, traumatic brain injury, or brain tumor, who have shoulder flexor/adductor strength ≥ MRC grade 2, limited spasticity (MAS ≤ 1+ for extensors/abductors), and K-MMSE ≥ 21.
✕Probably not a fit
Patients with severe spasticity (MAS ≥ 3), major psychiatric or neurodegenerative disorders, prior upper-limb disease limiting rehab, significant cognitive impairment, or skin conditions that prevent device use are unlikely to benefit from this intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Adults with late subacute or chronic hemiparesis and sufficient cognitive function will be assigned to use the Neofect Smart Board at home or to perform conventional home-based occupational therapy, and their outcomes will be compared. The study will measure clinical efficacy on upper limb function, usability of the smart board, and safety events. Training is performed at home with study oversight and planned outcome assessments at the clinical site. The protocol targets patients with mild-to-moderate shoulder strength and limited spasticity.
Why it matters
Potential benefit: If successful, this approach could improve arm function and independence while letting patients do guided rehabilitation at home.
How similar studies have gone: Technology-assisted and home-based upper limb rehabilitation approaches have shown promising results in prior trials, though device-specific evidence for the Neofect Smart Board is still limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients with neurological diseases aged 19 to 85 years old * Patients with hemiparesis lasting for more than 3 months due to neurological diseases (stroke, traumatic brain injury, brain tumor) and impaired upper limb function * Patients with shoulder flexor and adductor muscle strength of MRC grade 2 or higher * Patients with shoulder extensor and abductor spasticity of MAS grade 1+ or lower * Participants with sufficient cognitive function to understand the instructions from the researcher and the smart board, and to perform the tasks (K-MMSE ≥21) Exclusion Criteria: * pre-existing significant neurogenic disorders * major psychiatric disorders such as schizophrenia, bipolar disorder, or dementia * History of diseases that caused pain or muscle atrophy in the affected upper limb before the onset of the neurological disease, which interfered with rehabilitation * Severe spasticity of the affected upper limb (Modified Ashworth Scale score ≥3) * skin disorders or open wounds on the affected upper limb * Amputation, fractures, or soft tissue-related diseases or injuries on the affected upper limb * severe pain that interferes with rehabilitation of the affected upper limb (Numeric Rating Scale \> 6) * Inability to maintain a seated posture for more than 10 minutes, which is required for using the smart board * Significant visual impairment to the extent that the screen cannot be recognized when using the smart board
Where it's running
-
Samsung medical center
Seoul, South Korea Recruiting
Study contacts
- Study coordinator: Won Hyuk Chang
- Email: wh.chang@samsung.com
- Phone: +82-2-3410-6889
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Home-based smart glove therapy to improve arm movement after brain injury
This test tries the Neofect smart glove at home to see if it improves arm function more than usual home occupational therapy for adults (19–85) with late subacute or chronic arm weakness from brain injury.
-
Home-based exercise after cervical epidural steroid injection for neck and arm pain
This project will test whether adding an eight-week home exercise program after a cervical epidural steroid injection helps adults with chronic cervical radiculopathy have less pain and better neck function.
-
Home-based cardiac rehabilitation with family empowerment for people after acute coronary syndrome
This program will test whether a home-based cardiac rehab plan that trains and involves family members helps adults recovering from acute coronary syndrome improve exercise capacity and quality of life.
-
Intra-arterial tenecteplase given after thrombectomy for anterior large-vessel ischemic stroke with no-reflow or residual clot
This trial will test whether giving tenecteplase directly into the artery at the end of thrombectomy helps people with anterior large-vessel ischemic stroke treated within 24 hours of symptom onset.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.